2026-01-27 - Analysis Report
**Company Overview**
International Business Machines Corporation (IBM) is a technology and consulting firm that operates in the IT services, software, and hardware sectors.

**Return Rate Comparison**

* Cumulative return of review stock (IBM): 155.62%
* Cumulative return of comparison stock (S&P 500, VOO): 127.58%
* Divergence (simply the difference in cumulative return on the last day of the data): 155.62% - 127.58% = 28.04%

The IBM stock has shown a higher cumulative return compared to the S&P 500 (VOO) over the given period.

**Alpha and Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | -19.0% | 24.8% | -27.0% | 0.9 | 101.6B |
| 2017-2019  | -20.0% | 24.8% | -45.0% | 1.0 | 119.8B |
| 2018-2020  | -12.0% | 37.5% | -35.0% | 1.0 | 112.5B |
| 2019-2021  | 19.0% | 37.5% | -45.0% | 0.9 | 124.9B |
| 2020-2022  | 17.0% | 37.5% | 13.0% | 0.8 | 131.7B |
| 2021-2023  | 53.0% | 15.2% | 35.0% | 0.5 | 152.9B |
| 2022-2024  | 81.0% | 15.7% | 52.0% | 0.6 | 205.5B |
| 2023-2025  | 137.0% | 19.1% | 61.0% | 0.7 | 276.9B |

The Alpha value indicates the excess return of the stock compared to the market, and the Beta value measures the volatility of the stock relative to the market. The Alpha values ranged from -27.0% to 61.0%, while the Beta values ranged from 0.5 to 1.0.

**Recent Stock Price Fluctuations**

* Close: $296.33
* Last-market: {'price': 296.33, 'previousClose': 292.44, 'change': 1.33}
* 5-day SMA: $294.47
* 20-day SMA: $300.10
* 60-day SMA: $303.29

The 20-day and 60-day SMAs are above the current close price, indicating that the stock price has been trending upwards over the past 20-60 days.

**RSI, PPO, and Delta_Previous_Relative_Divergence Analysis**

* Market Risk Indicator (MRI): 0.70
* RSI: 50.74
* PPO: -0.30
* Hybrid Signal: Buy (Cash 0%)
Risk Level: Medium (MRI 0.70)
* Recent (20 days) relative divergence change: -2.80 (-): worsening
* 7-day Rank change: -12 (-): rank down
* 7-day Dynamic Expected Return change: 0.50 (+): improving
* Expected Return (%) = -6.10%
The Market Risk Indicator (MRI) suggests a medium-risk investment. The RSI and PPO values indicate a neutral market sentiment.

**Recent News & Significant Events**

* [2026-01-26] IBM stock price eyes a parabolic move ahead of its earnings - TradingView
* [2026-01-21] Buy The Dip In IBM Stock? - Forbes
* [2026-01-21] Dear IBM Stock Fans, Mark Your Calendars for January 28 - Barchart.com
* [2026-01-26] IBM Shares Gain Ahead of Quarterly Report - AD HOC NEWS
* [2026-01-22] Should You 'Buy' or 'Sell' IBM Stock Ahead of Q4 Earnings? - Yahoo Finance
* [2026-01-26] IBM stock rating reiterated at Underperform by Evercore ISI ahead of earnings - Investing.com Nigeria

These recent news and events suggest that the stock is expected to perform well ahead of its earnings report.

**Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.38 (~Buy)
- Opinions: 19
- Target Price (avg/high/low): 305.16 / 375.00 / 210.00

Most analysts recommend buying the stock, with an average target price of $305.16.

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-23 | 1.87 | 16.33 B$ |
| 2025-07-24 | 2.36 | 16.98 B$ |
| 2025-04-24 | 1.14 | 14.54 B$ |
| 2024-10-30 | -0.36 | 14.97 B$ |
| 2025-10-23 | -0.36 | 14.97 B$ |

The company's earnings per share (EPS) and revenue have been showing fluctuations over the past quarters.

**Financial Information**

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $16.33B | 57.31% |
| 2025-06-30 | $16.98B | 58.77% |
| 2025-03-31 | $14.54B | 55.23% |
| 2024-12-31 | $17.55B | 59.47% |
| 2024-09-30 | $14.97B | 56.26% |

The company's revenue and profit margin have been fluctuating over the past quarters.

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $27.91B | 6.25% |
| 2025-06-30 | $27.51B | 7.98% |
| 2025-03-31 | $26.88B | 3.92% |
| 2024-12-31 | $27.31B | 10.67% |
| 2024-09-30 | $24.45B | -1.35% |

The company's equity and return on equity (ROE) have been fluctuating over the past quarters.

**Comprehensive Analysis**

* IBM has shown a higher cumulative return compared to the S&P 500 (VOO) over the given period.
* The Alpha values have been ranging from -27.0% to 61.0%, while the Beta values have been ranging from 0.5 to 1.0.
* The stock price has been trending upwards over the past 20-60 days.
* Most analysts recommend buying the stock, with an average target price of $305.16.
* The company's earnings per share (EPS) and revenue have been showing fluctuations over the past quarters.
* The company's revenue and profit margin have been fluctuating over the past quarters.
* The company's equity and return on equity (ROE) have been fluctuating over the past quarters.

Overall, the comprehensive analysis suggests a mixed outlook for the company, with both positive and negative indicators.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.